C4 Therapeutics
Mathew Sowa began their career as a Graduate Student and Post-Doctoral Associate at Baylor College of Medicine. Mathew later worked as a Scientist IV at Cell Signaling Technology before moving on to roles at Warp Drive Bio, LLC, and Harvard Medical School. Currently, Mathew serves as the Vice President of Lead Discovery at C4 Therapeutics, Inc. Sowa's expertise lies in proteomics, UPS biology, and protein-protein interactions. Mathew's educational background includes a Ph.D. in Structural and Computational Biology and Molecular Biophysics from Baylor College of Medicine.
This person is not in the org chart
This person is not in any teams
C4 Therapeutics
6 followers
C4 Therapeutics (C4T) is a biopharmaceutical company focused on harnessing the body’s natural regulation of protein levels to develop novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases.